Trust signals
> Reviewed by FormBlends Medical Team · Last updated May 2026 · 12 sources cited · Author: FormBlends Editorial
Key Takeaways
- Ice Spice (Isis Gaston) has not confirmed or denied using any GLP-1 medication; no on-the-record statement has been located as of May 2026
- Her visible body changes between 2023 and 2025 are real but consistent with multiple possible causes, including ordinary changes in a touring artist in her mid-twenties
- Social-media speculation has been heavy, driven by before-and-after comparison posts that the TikTok and Instagram algorithms amplify regardless of evidence
- The speculation pattern around younger artists compresses faster than around older celebrities; what took a year to develop for an older star can develop in weeks for a Gen Z performer
- Until she chooses to address the topic specifically, the responsible position is to describe the gap in evidence rather than fill it with guesses
Direct answer
We do not know. Ice Spice has not publicly addressed Ozempic or other GLP-1 medications. Her body has changed visibly between 2023 and 2025, but the change is consistent with several causes (touring, dietary changes, ordinary body changes in a young adult, intentional fitness work, medication, or any combination). Speculation on social media has outpaced evidence. The honest framing is to acknowledge the gap rather than guess.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- What Ice Spice has actually said about her body
- The 2023-2025 timeline: when speculation started
- Why social-media speculation compresses faster for Gen Z artists
- What we can and cannot infer from appearance alone
- Possible explanations and their relative plausibility
- The clinical pattern of GLP-1 use and how to read it carefully
- Why younger artists face a different speculation pressure
- The decision framework for readers in their twenties
- What responsible coverage of celebrity bodies looks like
- The contrary view: is the speculation reasonable?
- FAQ
- Sources
What Ice Spice has actually said about her body
Isis Naija Gaston, who performs as Ice Spice, broke through in late 2022 with "Munch (Feelin' U)" and rose quickly. Her public commentary on her body has been limited and general rather than specific.
In interviews across 2023 and 2024, she has addressed appearance speculation in broad terms: pushing back on intrusive comments, describing the strangeness of having her body discussed publicly, and emphasizing that her music is what she would prefer to talk about. She has not given a cause-and-effect account of her appearance changes. She has not named medications. She has not denied medications.
This pattern is common among artists who view body discussion as out of bounds. It is not the same as a denial, and it is not a confirmation. It is a refusal to engage on the terms speculation demands.
No on-the-record statement specifically addressing Ozempic, Wegovy, semaglutide, or tirzepatide has been located as of May 2026. If she has spoken to friends, collaborators, or producers about her body, those conversations are not part of the public record.
The 2023-2025 timeline: when speculation started
The speculation cycle around her body tracks her rising visibility. The more public appearances she made, the more side-by-side comparison content circulated.
| Period | Public visibility | Speculation pattern |
|---|---|---|
| Late 2022 | "Munch" releases; viral breakout | Minimal body speculation; focus on music |
| Spring 2023 | Coachella debut; collaborations | Some commentary on appearance; speculation modest |
| Late 2023 | Grammy Best New Artist nomination | Public-eye fatigue; broader appearance discussion |
| Mid-2024 | Album rollout; festival run | First wave of GLP-1 speculation in comparison posts |
| Late 2024 to 2025 | Continued touring and visibility | Heavier speculation; viral comparison cycles |
Two features stand out. First, the speculation built during her most demanding work period (touring, recording, festival appearances). Second, the speculation never produced a definitive statement, either from her or from anyone close to her with direct knowledge.
Why social-media speculation compresses faster for Gen Z artists
Older celebrities (Oprah, Whoopi, Sharon Osbourne) faced GLP-1 speculation that built over months or years before they spoke about it. Younger artists face speculation that builds in weeks. The mechanism is platform structure.
Three platform features compress the timeline:
Feature 1: Before-and-after posts perform exceptionally well. TikTok and Instagram Reels reward visual comparison content with disproportionate reach. A side-by-side that picks the right two photos can reach millions of views in 24 hours. Older celebrities’ speculation lived on Twitter and gossip blogs; younger artists’ speculation lives in video formats with built-in virality.
Feature 2: Comment culture amplifies guessing. Comment sections on speculation posts function as collective theorizing. Users add detail ("her face changed," "look at her hands," "the cheek hollows") that aggregates into a pseudo-diagnostic consensus. None of the individual observations require evidence; in aggregate they create the impression of certainty.
Feature 3: Algorithmic clustering creates feedback loops. Once a user engages with one speculation post, the algorithm serves more. The result is a personalized feed in which speculation feels like a topic, not a rumor. Users in that feed often have no idea how marginal the speculation is outside their algorithmic bubble.
For Ice Spice, the speculation that exists is real in the sense that real users are posting and watching it. The speculation that exists is also flimsy in the sense that no part of it is supported by evidence. Both can be true at once.
What we can and cannot infer from appearance alone
The central problem with celebrity GLP-1 speculation is that appearance is a weak diagnostic signal. The signal-to-noise ratio is low even with photographs taken in similar conditions, and it gets worse when speculators compare photos with different lighting, makeup, angles, and styling.
What appearance can suggest:
- Direction of weight change (gain or loss)
- Rough order of magnitude over a long enough timeline
- Visible fatigue or illness in extreme cases
What appearance cannot reliably reveal:
- Specific medication used, if any
- Speed of change without controlled photo timelines
- Cause (diet, exercise, stress, illness, medication)
- Whether the change was intentional
- Whether the change is sustainable
For Ice Spice specifically, the most that appearance evidence supports is "she looks different in 2025 than in 2023." That is true and unremarkable. Beyond that, claims about cause are unsupported.
Possible explanations and their relative plausibility
Without disclosure, the honest approach is to list possibilities and assess each in light of what we know about her life.
Explanation 1: Touring and performance demands.
Touring schedules involve high physical output, irregular meals, sleep deprivation, and stress. Most artists who tour heavily lose weight during long runs, then partially regain when they go home. This is common enough that performance professionals build it into nutrition planning. Plausibility: high.
Explanation 2: Intentional fitness and dietary changes.
Artists in the music industry routinely work with trainers, nutritionists, and stylists who advise on body presentation. A young artist deciding to focus on fitness during a career rise is not unusual. Plausibility: high.
Explanation 3: Natural changes in a young adult body.
Bodies change between ages 22 and 25. Hormonal patterns shift, metabolism stabilizes from teenage variability, and lifestyle changes (different city, different friends, different work) produce body changes that have nothing to do with medication. Plausibility: high.
Explanation 4: GLP-1 medication.
Possible but not supported by evidence. Many adults in her age range and income bracket have access to GLP-1 medications, including off-label. The medication exists and is in use. Whether she specifically uses it is unknown. Plausibility: unknown.
Explanation 5: Stress, illness, or unrelated medical treatment.
Sudden weight changes in young public figures have many causes. We have no public information suggesting illness in her case, but the possibility cannot be ruled out without disclosure. Plausibility: unknown.
Explanation 6: Photographic and styling artifacts.
Lighting, posing, makeup contouring, and clothing fit can exaggerate apparent body change. Some of the visual difference in comparison posts likely reflects styling, not body. Plausibility: contributes to most cases.
The honest summary: explanations 1, 2, and 3 are individually likely and probably contribute to her appearance. Explanation 4 is possible but unproven. Speculation that focuses on explanation 4 to the exclusion of 1, 2, and 3 reflects audience preference, not evidence.
The clinical pattern of GLP-1 use and how to read it carefully
If you wanted to evaluate whether a celebrity is on a GLP-1 medication based on observable signals, here are the patterns clinicians look for (without claiming any of them are diagnostic).
| Signal | What it looks like | Why it matters |
|---|---|---|
| Gradual timeline | Steady reduction over 6-12 months, not sudden drops | STEP 1 (Wilding et al., NEJM 2021) shows characteristic curve |
| Reduced food noise language | Mentions of "not hungry," "food noise gone," "forgetting to eat" | Subjective correlate of appetite suppression |
| Nausea references | Casual mentions of feeling sick around food | Around 60% of GLP-1 patients report nausea in early weeks |
| Visible muscle loss | Reduced muscle tone alongside fat loss | GLP-1 weight loss includes 25-40% lean mass (Wilding et al. 2021) |
| Plateau then stability | Weight stabilizes around 6-9 months | Characteristic of medication-based weight loss |
| Discontinuation regain | If stopped, gradual regain over the following year | STEP 1 extension data shows ~65% regain at 12 months |
For Ice Spice, these signals are unevaluable from public material. She has not discussed food or appetite in interviews in ways that would map to GLP-1 language. She has not mentioned nausea. Her muscle tone in performance video looks intact, though performance choreography is not a controlled assessment. The plateau and discontinuation patterns require longer observation than has accumulated.
The honest read: we cannot tell. The signals are absent rather than contradictory, and absence of signal does not prove absence of medication.
Why younger artists face a different speculation pressure
Public conversation about an older celebrity’s weight has at least some social inhibition. Public conversation about a younger artist’s weight often does not.
The cultural pattern: viewers feel entitled to discuss young women’s bodies in ways they would not discuss men’s, would not discuss older women’s, and would not discuss their own. The entitlement is more visible online than in legacy media because comment sections strip away the friction of saying things to a person’s face.
For Ice Spice specifically, the cultural overlay includes race, hip-hop industry context, and a body type that has been intensely commodified and policed in pop culture. Speculation about her body sits inside larger conversations about who gets to be visible, who gets to be commercial, and who gets to have privacy.
None of this proves anything about her medication use. It does suggest that the volume of speculation reflects audience demand, not the strength of the evidence.
The decision framework for readers in their twenties
Some readers are curious about Ice Spice. Others are asking the question because they themselves are considering GLP-1 medications. The decision framework for the second group looks like this.
If you are in your twenties and meet FDA criteria:
- FDA criteria are BMI 30+, or BMI 27+ with a qualifying comorbidity (hypertension, dyslipidemia, type 2 diabetes)
- If you meet criteria, the same conversation applies as for older adults: clinical history, contraindications, cost, support
- Wegovy is approved for adolescents 12 and older with obesity, expanding the age range for the FDA-approved population
If you are in your twenties and do not meet criteria:
- Off-label cosmetic use in non-obese young adults is not supported by clinical evidence
- Long-term effects of medication use in this population are not characterized
- The risk-benefit calculation tilts against initiation in normal-weight young adults
If you are comparing yourself to a celebrity who may or may not be on the medication:
- Comparison-driven medication decisions are not clinical decisions
- You have no information about her starting point, current weight, or medical history
- Even if she were on a GLP-1 medication and disclosed it tomorrow, that would not establish that the medication is appropriate for you
What responsible coverage of celebrity bodies looks like
The Ice Spice case is a useful test of what responsible coverage looks like when evidence is genuinely thin.
Element 1: Name what you do not know. Most speculation posts do not. They state appearance claims as if they were medical facts. Responsible coverage states that no public statement has been made and that appearance is not diagnostic.
Element 2: Describe the plausibility of alternative causes. A change in a young touring artist has many possible causes. Listing them is more useful than fixating on one.
Element 3: Distinguish curiosity from accusation. "I wonder if she is on Ozempic" is a curiosity. "She is clearly on Ozempic" is an unsupported assertion. The line matters.
Element 4: Acknowledge that the person is allowed to keep her medical life private. The default assumption that we are entitled to know is the assumption that should be questioned.
The contrary view: is the speculation reasonable?
Several arguments can be made that the speculation about Ice Spice is reasonable, even without direct evidence.
Argument 1: Base rates have shifted.
If a meaningful percentage of celebrities in her age and income bracket use GLP-1 medications, the prior probability of any individual celebrity using is higher than it was three years ago. Reasonable speculation just reflects updated priors.
Argument 2: The pattern is suggestive.
A visible body change in an industry that rewards body change, in a year when GLP-1 access has expanded through telehealth platforms, in an artist with the financial means to access them, fits the pattern even if no individual signal is conclusive.
Argument 3: Silence is informative.
Celebrities who lose weight through diet and exercise typically discuss it. The absence of a public weight-loss narrative could reflect medication that the celebrity prefers not to discuss. This argument is weak (many people simply do not discuss their bodies), but it is not nothing.
The counter:
None of these arguments produce knowledge about her specifically. They produce a Bayesian update on the population of celebrities, which is different. Acting on a population-level inference as if it were a fact about an individual is a category error. The reasonable position is to acknowledge that GLP-1 use among young female artists is more common than it used to be, while declining to assert that any specific artist is using without disclosure.
FAQ
Is Ice Spice on Ozempic? Unknown. She has not confirmed or denied use of any GLP-1 medication. No on-the-record statement has been located as of May 2026. Speculation has been heavy on social media but is not supported by direct evidence.
How much weight has Ice Spice lost? No figure has been disclosed. Photographic comparison suggests a noticeable change between 2022-2023 and 2024-2025, but specific numbers circulating on social media are speculation.
Has Ice Spice talked about Ozempic? She has addressed appearance speculation in general terms in interviews and on social media, but no statement specifically addressing GLP-1 medications has been located.
Why do people think Ice Spice is on Ozempic? Social-media platforms reward before-and-after content with high engagement, and her visible 2023-2025 body changes have made her a frequent subject. The speculation reflects platform incentives and cultural patterns, not direct evidence.
What is the safest way to lose weight in your twenties? Discuss your goals with a clinician. For most young adults at a healthy weight, intentional weight loss is not medically indicated. For those who meet FDA criteria for medical weight loss, a coordinated plan with a clinician is the safer path than self-directed off-label medication use.
Can you take Ozempic at age 24? If you meet FDA criteria for the diagnosis (type 2 diabetes for Ozempic, obesity for Wegovy at the same molecule) and a clinician determines it is appropriate. Wegovy is approved for adolescents 12 and older with obesity, so the medication has been studied in younger populations within an obesity context.
What does Ice Spice eat? She has not given detailed dietary interviews. Her public statements have not focused on diet or food culture.
Is Ice Spice working out? She has shown gym and movement content occasionally on social media. The intensity and consistency of her training are not public.
What is Ozempic face? A term describing facial volume loss from rapid weight reduction. The phenomenon is not specific to GLP-1 medications; any significant weight loss can produce similar changes. Whether someone has "Ozempic face" is not a reliable diagnostic for GLP-1 use.
Did Ice Spice deny Ozempic? Not specifically. She has pushed back on body-related commentary in general terms. The absence of a specific denial is not the same as a confirmation.
Are GLP-1 medications popular with rappers and music industry figures? Anecdotally yes, but systematic data are not available. The use of weight-management medications in entertainment industries has historical precedent (from amphetamines in the mid-20th century onward); GLP-1 medications are a newer addition.
Should I take Ozempic to look like Ice Spice? No. Medication decisions should be based on your medical situation, not on the appearance of a public figure. Even if she were confirmed to use the medication, her starting point, body composition, and clinical context would not match yours.
Sources
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
- Kelly AS et al. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity. New England Journal of Medicine. 2020.
- Weghuber D et al. Once-Weekly Semaglutide in Adolescents with Obesity. New England Journal of Medicine. 2022.
- Pearl RL et al. Weight Bias and Stigma: Public Health Implications and Structural Solutions. Obesity. 2023.
- Davies MJ et al. Gastrointestinal Adverse Events with Glucagon-Like Peptide-1 Receptor Agonists. Diabetes Care. 2023.
- Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024.
- FDA Drug Approvals Database. Wegovy approval for adolescents 12 and older with obesity. 2022.
- Pew Research Center. Social Media and the News Habits of Younger Americans. 2024.
- Brandwatch. Social Listening Report: GLP-1 Medication Discussion 2021-2024. 2024.
- American Academy of Pediatrics. Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity. 2023.
Footer disclaimers
Platform Disclaimer. FormBlends connects patients with independent licensed clinicians and U.S.-based 503A compounding pharmacies. FormBlends does not itself prescribe, dispense, or manufacture medication. Prescribing decisions belong to clinicians who evaluate each patient.
Compounded Medication Notice. Compounded semaglutide and compounded tirzepatide are prepared by 503A compounding pharmacies in response to individual prescriptions. They are not FDA-approved products and have not been reviewed for safety or efficacy by the FDA. They are not interchangeable with brand-name Ozempic, Wegovy, Mounjaro, or Zepbound.
Speculation Notice. This page discusses publicly available information and the gaps in that information. It does not assert any claim about Ice Spice’s personal medication use. Any conclusions a reader might draw should account for the absence of direct evidence on the question.
Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Ice Spice, her record label, or any company referenced on this page.